UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trial

The lancet oncology, 2014-02, Vol.15 (2), p.143-155

2014

Volltextzugriff (PDF)

Randomized, controlled trial of irinotecan plus infusional, bolus, or oral fluoropyrimidines in first-line treatment of metastatic colorectal cancer: updated results from the BICC-C study

Journal of clinical oncology, 2008-02, Vol.26 (4), p.689-690

2008

Volltextzugriff (PDF)

Randomized, Controlled Trial of Irinotecan Plus Infusional, Bolus, or Oral Fluoropyrimidines in First-Line Treatment of Metastatic Colorectal Cancer: Results From the BICC-C Study

Journal of clinical oncology, 2007-10, Vol.25 (30), p.4779-4786

2007

Volltextzugriff (PDF)

Nintedanib Plus Pemetrexed/Cisplatin in Patients With Malignant Pleural Mesothelioma: Phase II Results From the Randomized, Placebo-Controlled LUME-Meso Trial

Journal of clinical oncology, 2017-11, Vol.35 (31), p.3591-3600

2017

Volltextzugriff (PDF)

Digital preservation in institutional repositories: a systematic literature review

Digital library perspectives, 2022-04, Vol.38 (2), p.161-174

2022

Volltextzugriff (PDF)

Nintedanib plus pemetrexed versus placebo plus pemetrexed in patients with relapsed or refractory, advanced non-small cell lung cancer (LUME-Lung 2): A randomized, double-blind, phase III trial

Lung cancer (Amsterdam, Netherlands), 2016-12, Vol.102, p.65-73

2016

Volltextzugriff (PDF)

Analysis of patient-reported outcomes from the LUME-Lung 1 trial: A randomised, double-blind, placebo-controlled, Phase III study of second-line nintedanib in patients with advanced non-small cell lung cancer

European journal of cancer (1990), 2015-02, Vol.51 (3), p.317-326

2015

Volltextzugriff (PDF)

Anti-angiogenic-specific adverse events in patients with non-small cell lung cancer treated with nintedanib and docetaxel

Lung cancer (Amsterdam, Netherlands), 2015-11, Vol.90 (2), p.267-273

2015

Volltextzugriff (PDF)

Defining aggressive or early progressing nononcogene-addicted non-small-cell lung cancer: a separate disease entity?

Future oncology (London, England), 2019-04, Vol.15 (12), p.1363-1383

2019

Volltextzugriff (PDF)

Comparing Safety and Efficacy of First-line Irinotecan/Fluoropyrimidine Combinations in Elderly Versus Nonelderly Patients With Metastatic Colorectal Cancer: Findings From the Bolus, Infusional, or Capecitabine With Camptostar-Celecoxib Study

Cancer, 2009-06, Vol.115 (12), p.2617-2629

2009

Volltextzugriff (PDF)

Response to 'Dai W et al. Am J Cancer Res 2015;5(10):3270-3275' from the makers of nintedanib

American journal of cancer research, 2016-01, Vol.6 (7), p.1547-1548

2016

Volltextzugriff (PDF)

Time since start of first-line therapy as a predictive clinical marker for nintedanib in patients with previously treated non-small cell lung cancer

ESMO open, 2017, Vol.2 (1), p.e000102-e000102, Article e000102

2017

Volltextzugriff (PDF)

RePEc o cómo proveer servicios de valor añadido a una comunidad de investigadores

Métodos de información, 2013-12, Vol.4 (6), p.5-15

Barrueco Cruz, José Manuel

2013

Volltextzugriff (PDF)

Some aspects of citation indexes in Spain: A comparative analysis

Scientometrics, 2008-05, Vol.75 (2), p.313-318

2008

Volltextzugriff (PDF)

Comparing safety and efficacy of first‐line irinotecan/fluoropyrimidine combinations in elderly versus nonelderly patients with metastatic colorectal cancer

Cancer, 2009-06, Vol.115 (12), p.2617-2629

2009

Volltextzugriff (PDF)

Nuevas vías de depósito, nuevos proyectos: consolidación del repositorio institucional RODERIC

Métodos de información, 2013-12, Vol.4 (6), p.31-40

2013

Volltextzugriff (PDF)

Double-stranded DNA in exosomes： a novel biomarker in cancer detection

Cell research, 2014-06, Vol.24 (6), p.766-769

2014

Volltextzugriff (PDF)

RePEc o cómo proveer servicios de valor añadido a una comunidad de investigadores

Métodos de información, 2013-11, Vol.4 (6), p.5-15

Barrueco, José Manuel

2013

Volltextzugriff (PDF)

Nuevas vías de depósito, nuevos proyectos: consolidación del repositorio institucional RODERIC

Métodos de información, 2013-11, Vol.4 (6), p.31-42

2013

Volltextzugriff (PDF)

Algunas reflexiones sobre acceso abierto, repositorios y cooperación

CLIP de SEDIC : Revista de la Sociedad Española de Documentación e Información Científica, 2021-06 (83), p.9-15

Barrueco, José Manuel

2021

Volltextzugriff (PDF)

In Reply

Journal of clinical oncology, 2008-04, Vol.26 (11), p.1908-1909

2008

Volltextzugriff (PDF)

BIBF1120 (Vargatef) Inhibits Preretinal Neovascularization and Enhances Normal Vascularization in a Model of Vasoproliferative Retinopathy

Investigative ophthalmology & visual science, 2015-12, Vol.56 (13), p.7897-7907

2015

Volltextzugriff (PDF)

Un archivo abierto en ciencias de la documentación e información

El profesional de la informacion, 2004, Vol.13 (5), p.346-352

2004

Volltextzugriff (PDF)

Reference linking: un nuevo concepto para facilitar el acceso a la literatura científica

El profesional de la informacion, 2002, Vol.11 (4), p.278-282

BARRUECO, José Manuel

2002

Volltextzugriff (PDF)

1 – 25 von 178

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(147)
Mit Volltextzugriff
(166)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(81)
Life Sciences & Biomedicine
(76)
Humans
(55)
Female
(31)
Male
(22)
Animals
(18)
Middle Aged
(18)
Oncology
(18)
Aged
(16)
Biological And Medical Sciences
(15)
Pulmonary/respiratory
(15)
Microbiology
(14)
Otorhinolaryngology
(13)
Respiratory System
(13)
Cell Biology
(12)
Cell Line, Tumor
(11)
Fundamental And Applied Biological Sciences. Psychology
(11)
Mice
(11)
Adult
(10)
Smoking
(10)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trial

Randomized, controlled trial of irinotecan plus infusional, bolus, or oral fluoropyrimidines in first-line treatment of metastatic colorectal cancer: updated results from the BICC-C study

Randomized, Controlled Trial of Irinotecan Plus Infusional, Bolus, or Oral Fluoropyrimidines in First-Line Treatment of Metastatic Colorectal Cancer: Results From the BICC-C Study

Nintedanib Plus Pemetrexed/Cisplatin in Patients With Malignant Pleural Mesothelioma: Phase II Results From the Randomized, Placebo-Controlled LUME-Meso Trial

Digital preservation in institutional repositories: a systematic literature review

Nintedanib in combination with pemetrexed and cisplatin for chemotherapy-naive patients with advanced malignant pleural mesothelioma (LUME-Meso): a double-blind, randomised, placebo-controlled phase 3 trial

Nintedanib plus pemetrexed versus placebo plus pemetrexed in patients with relapsed or refractory, advanced non-small cell lung cancer (LUME-Lung 2): A randomized, double-blind, phase III trial

Analysis of patient-reported outcomes from the LUME-Lung 1 trial: A randomised, double-blind, placebo-controlled, Phase III study of second-line nintedanib in patients with advanced non-small cell lung cancer

Anti-angiogenic-specific adverse events in patients with non-small cell lung cancer treated with nintedanib and docetaxel

Defining aggressive or early progressing nononcogene-addicted non-small-cell lung cancer: a separate disease entity?

Comparing Safety and Efficacy of First-line Irinotecan/Fluoropyrimidine Combinations in Elderly Versus Nonelderly Patients With Metastatic Colorectal Cancer: Findings From the Bolus, Infusional, or Capecitabine With Camptostar-Celecoxib Study

Response to 'Dai W et al. Am J Cancer Res 2015;5(10):3270-3275' from the makers of nintedanib

Time since start of first-line therapy as a predictive clinical marker for nintedanib in patients with previously treated non-small cell lung cancer

RePEc o cómo proveer servicios de valor añadido a una comunidad de investigadores

Some aspects of citation indexes in Spain: A comparative analysis

Comparing safety and efficacy of first‐line irinotecan/fluoropyrimidine combinations in elderly versus nonelderly patients with metastatic colorectal cancer

Nuevas vías de depósito, nuevos proyectos: consolidación del repositorio institucional RODERIC

Double-stranded DNA in exosomes： a novel biomarker in cancer detection

RePEc o cómo proveer servicios de valor añadido a una comunidad de investigadores

Nuevas vías de depósito, nuevos proyectos: consolidación del repositorio institucional RODERIC

Algunas reflexiones sobre acceso abierto, repositorios y cooperación

In Reply

BIBF1120 (Vargatef) Inhibits Preretinal Neovascularization and Enhances Normal Vascularization in a Model of Vasoproliferative Retinopathy

Un archivo abierto en ciencias de la documentación e información

Reference linking: un nuevo concepto para facilitar el acceso a la literatura científica

Suchergebnisse filtern